Two new studies have shown that elevated fasting blood glucose (FBG), whether a patient has been diagnosed with diabetes or not, could be a risk factor for severe illness in patients with COVID-19. Authors of the first study, based on patients at a hospital in Guangzhou, Guangdong, China and published in Diabetes, Obesity and Metabolism, found an FBG of ≥6.23 mmol/L to be an optimal cutoff for poor prognosis within 30 days of hospital admission, …
Read More









